26.04.2023 12:57:26
|
Boston Scientific Boosts FY23 Adj. EPS, Sales Growth Outlook - Update
(RTTNews) - While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2023.
For fiscal 2023, the company now projects earnings in a range of $0.93 to $1.02 per share and adjusted earnings in a range of $1.90 to $1.96 per share on net sales growth of about 8.5 to 10.5 percent, with organic net sales growth of 8 to 10 percent.
Previously, the company expected earnings in a range of $1.11 to $1.21 per share and adjusted earnings in a range of $1.86 to $1.93 per share on net sales growth of about 5 to 7 percent, with organic net sales growth of about 6 to 8 percent.
On average, analysts polled by Thomson Reuters expect earnings of $1.91 per share on revenue growth of 6.8 percent to $13.55 billion for the year. Analysts' estimates typically exclude special items.
For the second quarter, the company estimates earnings in a range of $0.23 to $0.27 per share and adjusted earnings in a range of $0.48 to $0.50 per share on net sales growth of about 6.5 to 8.5 percent, with organic net sales growth of about 7 to 9 percent.
Analysts expect earnings of $0.48 per share on revenue growth of 6.0 percent to $3.44 billion for the quarter.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Boston Scientific Corp.mehr Nachrichten
28.01.25 |
S&P 500-Papier Boston Scientific-Aktie: So viel hätten Anleger an einem Boston Scientific-Investment von vor einem Jahr verdient (finanzen.at) | |
21.01.25 |
S&P 500-Wert Boston Scientific-Aktie: So viel hätten Anleger an einem Boston Scientific-Investment von vor 10 Jahren verdient (finanzen.at) | |
21.01.25 |
Erste Schätzungen: Boston Scientific öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
14.01.25 |
S&P 500-Wert Boston Scientific-Aktie: So viel Gewinn hätte ein Boston Scientific-Investment von vor 5 Jahren eingefahren (finanzen.at) | |
08.01.25 |
S&P 500-Handel aktuell: S&P 500 bewegt sich zum Handelsende im Plus (finanzen.at) | |
08.01.25 |
Verluste in New York: Das macht der S&P 500 aktuell (finanzen.at) | |
08.01.25 |
Aufschläge in New York: Anleger lassen S&P 500 am Mittwochmittag steigen (finanzen.at) | |
08.01.25 |
Zurückhaltung in New York: S&P 500 präsentiert sich zum Start schwächer (finanzen.at) |
Analysen zu Boston Scientific Corp.mehr Analysen
Aktien in diesem Artikel
Boston Scientific Corp. | 100,00 | 1,52% |